Trial · NCT00803205
Results by group98
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 98
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Predicted Function (Percent-Predicted) of Forced Expiratory Volume in One Second (FEV1) at Baseline | Ataluren | 62.092 | Standard Deviation 13.6159 | percentage of predicted FEV1 | |
| Percentage of Predicted Function (Percent-Predicted) of Forced Expiratory Volume in One Second (FEV1) at Baseline | Placebo | 60.232 | Standard Deviation 15.1437 | percentage of predicted FEV1 | |
| Percentage Change From Baseline in Percent-Predicted of FEV1 at Week 48 | Ataluren | -2.534 | Standard Deviation 13.2452 | percent change | |
| Percentage Change From Baseline in Percent-Predicted of FEV1 at Week 48 | Placebo | -5.500 | Standard Deviation 12.5595 | percent change | |
| Rate of Pulmonary Exacerbations as Defined by Modified Fuch's Criteria Over 48 Weeks | Ataluren | 1.42 | 95% Confidence Interval 1.05 to 1.79 | exacerbations | |
| Rate of Pulmonary Exacerbations as Defined by Modified Fuch's Criteria Over 48 Weeks | Placebo | 1.78 | 95% Confidence Interval 1.38 to 2.17 | exacerbations | |
| Change From Baseline in Awake Cough Hourly Rate at Week 48 | Ataluren | Baseline | 28.218 | Standard Deviation 20.2726 | coughs/hour |
| Change From Baseline in Awake Cough Hourly Rate at Week 48 | Placebo | Baseline | 24.472 | Standard Deviation 16.7828 | coughs/hour |
| Change From Baseline in Awake Cough Hourly Rate at Week 48 | Ataluren | Change From Baseline | -0.595 | Standard Deviation 18.3221 | coughs/hour |
| Change From Baseline in Awake Cough Hourly Rate at Week 48 | Placebo | Change From Baseline | 0.882 | Standard Deviation 14.3936 | coughs/hour |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Ataluren | Aged 6-13 years, Baseline | 77.78 | Standard Deviation 11.070 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Placebo | Aged 6-13 years, Baseline | 79.49 | Standard Deviation 16.879 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Ataluren | Aged 6-13 years, Change From Baseline | -0.69 | Standard Deviation 12.028 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Placebo | Aged 6-13 years, Change From Baseline | -3.57 | Standard Deviation 21.973 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Ataluren | Age ≥14 years , Baseline | 70.06 | Standard Deviation 15.678 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Placebo | Age ≥14 years , Baseline | 65.95 | Standard Deviation 16.771 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Ataluren | Age ≥14 years, Change From Baseline | -2.81 | Standard Deviation 18.365 | units on a scale |
| Change From Baseline in the Respiratory Domain Score of the Revised Cystic Fibrosis Questionnaire (CFQ-R) at Week 48 | Placebo | Age ≥14 years, Change From Baseline | -3.32 | Standard Deviation 16.245 | units on a scale |
| Percent-Predicted of Forced Vital Capacity (FVC) at Baseline | Ataluren | 78.332 | Standard Deviation 13.1825 | percentage of predicted FVC | |
| Percent-Predicted of Forced Vital Capacity (FVC) at Baseline | Placebo | 76.609 | Standard Deviation 13.3711 | percentage of predicted FVC |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00803205/results